JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Phibro Animal Health Corp

Fechado

SetorSaúde

28.56 1.96

Visão Geral

Variação de preço das ações

24h

Atual

Mín

27.78

Máximo

28.72

Indicadores-chave

By Trading Economics

Rendimento

18M

21M

Vendas

39M

348M

P/E

Médio do Setor

34.795

34.393

Rendimento de Dividendos

1.84

Margem de lucro

6.003

Funcionários

1,940

EBITDA

26M

51M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+2.31% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.84%

2.54%

Próximos Ganhos

27 de ago. de 2025

Próxima data de dividendos

24 de set. de 2025

Próxima data de ex-dividendo

3 de set. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

107M

1.1B

Abertura anterior

26.6

Fecho anterior

28.56

Sentimento de Notícias

By Acuity

36%

64%

115 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Phibro Animal Health Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de ago. de 2025, 17:49 UTC

Grandes Movimentos do Mercado

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 de ago. de 2025, 17:18 UTC

Grandes Movimentos do Mercado

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 de ago. de 2025, 16:25 UTC

Ganhos

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 de ago. de 2025, 23:50 UTC

Conversa de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

11 de ago. de 2025, 23:42 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

11 de ago. de 2025, 23:42 UTC

Conversa de Mercado

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 de ago. de 2025, 23:36 UTC

Conversa de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 de ago. de 2025, 23:32 UTC

Conversa de Mercado

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 de ago. de 2025, 23:02 UTC

Conversa de Mercado

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 de ago. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

11 de ago. de 2025, 20:37 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 de ago. de 2025, 20:37 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 de ago. de 2025, 20:37 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 de ago. de 2025, 20:22 UTC

Ganhos

Exodus Movement 2Q Rev $25.8M >EXOD

11 de ago. de 2025, 20:14 UTC

Conversa de Mercado

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 de ago. de 2025, 19:12 UTC

Conversa de Mercado

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 de ago. de 2025, 18:56 UTC

Conversa de Mercado

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 de ago. de 2025, 18:31 UTC

Conversa de Mercado

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 de ago. de 2025, 17:43 UTC

Conversa de Mercado

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 de ago. de 2025, 17:28 UTC

Conversa de Mercado

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 de ago. de 2025, 17:16 UTC

Conversa de Mercado

Commodity Longs Fall to 11-Month Low -- Market Talk

11 de ago. de 2025, 16:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 de ago. de 2025, 16:27 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Says Sabadell Offer Remains in Effect

11 de ago. de 2025, 16:26 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 de ago. de 2025, 16:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Banco de Sabadell Announced TSB Sale on July 1

11 de ago. de 2025, 16:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Comparação entre Pares

Variação de preço

Phibro Animal Health Corp Previsão

Preço-alvo

By TipRanks

2.31% parte superior

Previsão para 12 meses

Média 28.75 USD  2.31%

Máximo 35 USD

Mínimo 24 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Phibro Animal Health Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

1

Comprar

3

Manter

0

Vender

Pontuação Técnica

By Trading Central

17 / N/ASuporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

115 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.